Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Marek

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Journal of Parkinson'S Disease|July 26, 2024
Modeling of Parkinson's Disease Progression and Implications for Detection of Disease Modification in Treatment TrialsBenjamin Ribba, Tanya Simuni, Kenneth Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2010
Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD studyAnthony H V Schapira, Stefan Albrecht, Paolo Barone, et al.
Nature Medicine|January 30, 2025
Toward a biological definition of neuronal and glial synucleinopathiesClaudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Molecular Genetics & Genomic Medicine|October 6, 2015
Novel recruitment strategy to enrich for LRRK2 mutation carriersTatiana Foroud, Danielle Smith, Jacqueline Jackson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findingsLama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Annals of Clinical and Translational Neurology|July 8, 2016
Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseTanya Simuni, Jeffrey D Long, Chelsea Caspell-Garcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2017
Cognition and the course of prodromal Parkinson's diseaseDaniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
Expert Review of Neurotherapeutics|November 5, 2016
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspectiveStuart H Isaacson, Stanley Fisher, Fiona Gupta, et al.
Movement Disorders Clinical Practice|October 27, 2018
Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's DiseaseRoger Kurlan, Bernard Ravina, Shirley Eberly, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Journal of Parkinson'S Disease|July 26, 2024
Modeling of Parkinson's Disease Progression and Implications for Detection of Disease Modification in Treatment TrialsBenjamin Ribba, Tanya Simuni, Kenneth Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2010
Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD studyAnthony H V Schapira, Stefan Albrecht, Paolo Barone, et al.
Nature Medicine|January 30, 2025
Toward a biological definition of neuronal and glial synucleinopathiesClaudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Molecular Genetics & Genomic Medicine|October 6, 2015
Novel recruitment strategy to enrich for LRRK2 mutation carriersTatiana Foroud, Danielle Smith, Jacqueline Jackson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findingsLama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Annals of Clinical and Translational Neurology|July 8, 2016
Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseTanya Simuni, Jeffrey D Long, Chelsea Caspell-Garcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2017
Cognition and the course of prodromal Parkinson's diseaseDaniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
Expert Review of Neurotherapeutics|November 5, 2016
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspectiveStuart H Isaacson, Stanley Fisher, Fiona Gupta, et al.
Movement Disorders Clinical Practice|October 27, 2018
Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's DiseaseRoger Kurlan, Bernard Ravina, Shirley Eberly, et al.
Pageof 15